Haverford Trust Co purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 272,415 shares of the company’s stock, valued at approximately $35,005,000. Haverford Trust Co owned 0.21% of Merck KGaA as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of MKGAF. Frazier Financial Advisors LLC purchased a new stake in shares of Merck KGaA in the second quarter valued at about $25,000. Rakuten Securities Inc. purchased a new position in Merck KGaA during the second quarter worth about $27,000. Bard Associates Inc. purchased a new position in Merck KGaA during the second quarter worth about $60,000. Kilter Group LLC acquired a new position in Merck KGaA in the 2nd quarter valued at about $62,000. Finally, Addison Advisors LLC acquired a new position in Merck KGaA in the 2nd quarter valued at about $90,000. Institutional investors and hedge funds own 0.10% of the company’s stock.
Merck KGaA Stock Performance
Merck KGaA stock opened at $163.21 on Friday. The firm has a 50 day simple moving average of $162.62 and a 200-day simple moving average of $148.46. The stock has a market cap of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a 1-year low of $116.68 and a 1-year high of $175.56.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Further Reading
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
